Cargando…

The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia

The endocannabinoid system is widespread throughout the central nervous system and its type 1 receptor (CB1) plays a crucial role in preventing the neurotoxicity caused by activation of glutamate N-methyl-D-aspartate receptors (NMDARs). Indeed, it is the activity of NMDARs themselves that provides t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Blázquez, Pilar, Rodríguez-Muñoz, María, Garzón, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877778/ https://www.ncbi.nlm.nih.gov/pubmed/24427139 http://dx.doi.org/10.3389/fphar.2013.00169

Ejemplares similares

HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity
por: Vicente-Sánchez, Ana, et al.
Publicado: (2013)

Neonatal NMDA Receptor Blockade Disrupts Spike Timing and Glutamatergic Synapses in Fast Spiking Interneurons in a NMDA Receptor Hypofunction Model of Schizophrenia
por: Jones, Kevin S., et al.
Publicado: (2014)

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
por: Nakazawa, Kazu, et al.
Publicado: (2017)

Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes
por: Rompala, Gregory R., et al.
Publicado: (2013)

Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction
por: Nakao, Kazuhito, et al.
Publicado: (2019)

Aberrant maturation and connectivity of prefrontal cortex in schizophrenia – contribution of NMDA receptor development and hypofunction
por: Gao, Wen-Jun, et al.
Publicado: (2022)

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
por: Rodríguez-Muñoz, María, et al.
Publicado: (2016)

Dual orexin/hypocretin receptor antagonism attenuates attentional impairments in an NMDA receptor hypofunction model of schizophrenia
por: Maness, Eden B., et al.
Publicado: (2023)

Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022)
por: Reilly, Thomas J.
Publicado: (2022)

The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain
por: Rodríguez-Muñoz, María, et al.
Publicado: (2021)

Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors
por: Rodríguez-Muñoz, María, et al.
Publicado: (2018)

5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction
por: Nakao, Kazuhito, et al.
Publicado: (2022)

12.2 METABOLIC CONSEQUENCES OF DEVELOPMENTAL NMDA RECEPTOR HYPOFUNCTION
por: Funk, Adam, et al.
Publicado: (2018)

NMDA Receptor Hypofunction in the Aging-Associated Malfunction of Peripheral Tissue
por: Rivera-Villaseñor, Angélica, et al.
Publicado: (2021)

mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia
por: Wang, Hoau-Yan, et al.
Publicado: (2018)

Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia
por: Kehrer, Colin, et al.
Publicado: (2008)

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
por: Snyder, Melissa A., et al.
Publicado: (2013)

A circuit mechanism for decision-making biases and NMDA receptor hypofunction
por: Cavanagh, Sean Edward, et al.
Publicado: (2020)

Premature commitment to uncertain decisions during human NMDA receptor hypofunction
por: Salvador, Alexandre, et al.
Publicado: (2022)

The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders
por: Rodríguez-Muñoz, María, et al.
Publicado: (2015)

PM368. Ketogenic diet normalises schizophrenia-like behaviours in acute and chronic NMDA-receptor hypofunction models
por: Kraeuter, Ann-Katrin, et al.
Publicado: (2016)

Calmodulin Supports TRPA1 Channel Association with Opioid Receptors and Glutamate NMDA Receptors in the Nervous Tissue
por: Cortés-Montero, Elsa, et al.
Publicado: (2020)

Glutamatergic Dysbalance and Oxidative Stress in In Vivo and In Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism
por: Genius, Just, et al.
Publicado: (2013)

NMDA Receptor Function During Senescence: Implication on Cognitive Performance
por: Kumar, Ashok
Publicado: (2015)

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
por: Rodríguez-Muñoz, María, et al.
Publicado: (2018)

Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction
por: Islam, Rehnuma, et al.
Publicado: (2017)

Neuronal Cannabinoid CB(1) Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling
por: Costas-Insua, Carlos, et al.
Publicado: (2023)

Ligands Exert Biased Activity to Regulate Sigma 1 Receptor Interactions With Cationic TRPA1, TRPV1, and TRPM8 Channels
por: Cortés-Montero, Elsa, et al.
Publicado: (2019)

The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control
por: Rodríguez-Muñoz, María, et al.
Publicado: (2015)

Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
por: Aguilar, David D., et al.
Publicado: (2021)

The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse
por: Fan, Xuelai, et al.
Publicado: (2014)

Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
por: Ibarra-Lecue, Inés, et al.
Publicado: (2020)

Subunit contribution to NMDA receptor hypofunction and redox sensitivity of hippocampal synaptic transmission during aging
por: Kumar, Ashok, et al.
Publicado: (2019)

Mu-Opioid Receptors Transiently Activate the Akt-nNOS Pathway to Produce Sustained Potentiation of PKC-Mediated NMDAR-CaMKII Signaling
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2010)

Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies
por: Carvajal, Francisco J., et al.
Publicado: (2016)

GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
por: Nakao, Kazuhito, et al.
Publicado: (2020)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness
por: Hakami, Tahir, et al.
Publicado: (2009)

Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p14b5egllhgd97308egi1fo03h